Overview / Abstract: |
Target Audience This activity is intended for gynecologic, medical, surgical and radiation oncologists, oncology nurses, nurse practitioners, pharmacists, gynecologists, primary care physicians, physician assistants, and other HCPs who are interested/involved in the therapeutic management of patients with ovarian cancer. Upon completion of this activity, participants should be able to: Integrate the latest maintenance setting data on PARP inhibitors into patients’ treatment algorithms |
Expiration |
Dec 20, 2019 |
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Shannon N. Westin, MD, MPH, FACOG Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery Professor & Executive Director, Cancer Network Research, Department of Gynecologic Oncology & Reproductive Medicine Associate Professor |
Activity Specialities / Related Topics |
OB/GYN / Women's Health, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
Clovis Oncology, Inc. AstraZeneca, and TESARO. |
Keywords / Search Terms |
Relias LLC ovarian, cervical Free CE CME |